Leena T Rahmat
Overview
Explore the profile of Leena T Rahmat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kalmbach K, Rahmat L, Wos J, Daniel N
Clin Pract Cases Emerg Med
. 2019 Nov;
3(4):398-400.
PMID: 31763598
Tumor lysis syndrome is an oncologic emergency that can present with variable symptoms and is truly a laboratory-based diagnosis without pathognomonic clinical findings. The classical teaching is to consider this...
2.
Rahmat L, Brandt P, Ali S
Clin Case Rep
. 2019 Mar;
7(2):272-274.
PMID: 30847188
Vincristine-induced vocal cord palsy (VCP) is a rare but critical complication. Prompt recognition of VCP is imperative. Vincristine-induced VCP is reversible, and a complete remission of a lymphoma is still...
3.
Rahmat L, Damon L
Case Rep Hematol
. 2019 Jan;
2018:7267920.
PMID: 30662779
Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic disorder which shares clinical and morphological features of myelodysplastic syndrome and myeloproliferative neoplasms. Conventional therapeutic options include hydroxyurea, hypomethylating agents, and systemic...
4.
Brandt P, Rahmat L, Ali S
Clin Case Rep
. 2019 Jan;
7(1):164-169.
PMID: 30656034
Hepatosplenic gamma-delta T-cell lymphoma with concurrent hemophogocytic lymphohistiocytosis is a rare but well-recognized clinical scenario, associated with a grim prognosis. Clinicians must be aware of this aggressive type of lymphoma...
5.
Rahmat L, Nguyen A, Abdulhaq H, Prakash S, Logan A, Mannis G
Case Rep Hematol
. 2018 Sep;
2018:6092646.
PMID: 30225152
Long-term disease-free survival in adults with T-cell acute lymphoblastic leukemia (T-ALL) remains poor, particularly after relapse, with few available salvage options. Preclinical data suggest that inhibition of the antiapoptotic protein...